Former President, Chief Operating Officer and Secretary · Q32 Bio Inc. (QTTB)

Paul Alloway

A named executive officer of Q32 Bio in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$758,139

Salary $115,049Stock awards $0Bonus $269,748

FY2022: $868,639

3rd of 3 named executive officers at Q32 Bio by FY2024 total.

3 named officers on file for Q32 Bio, FY2024

Paul Alloway’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Q32 Bio’s whole pay program stands against its peers

  • Q32 Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on QTTB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2025 (DEF 14A).

Free

Get Paul Alloway’s full pay file as a PDF — free

More than this page: up to 10 years of Paul’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Paul Alloway compensation by year

Q32 Bio Summary Compensation Table · all 2 fiscal years held
In US dollars, as Q32 Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2024
Salary$415,700$115,049
Bonus$70,771$269,748
Stock awards$43,360$0
Option awards$163,828$0
Non-equity incentive$166,280$0
Pension and deferred compensation$0$0
All other$8,700$373,342
Total$868,639$758,139

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Q32 Bio Inc. DEF 14A filed April 29, 2025, accession 0000950170-25-059558, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Q32 Bio Inc. filed document, accession 0000950170-25-059558. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.

$869K
$758K
FY22
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU16,000$20,160—
RSU8,710$10,975—
Option41,146—$13.78
Option73,230—$2.71
Option44,271—$12.66

Per the Outstanding Equity Awards at Fiscal Year-End table in Q32 Bio Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Q32 Bio’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Jodie MorrisonChief Executive Officer and Director$6,003,238
Lee KalowskiChief Financial Officer and President$2,854,009
Paul Alloway · this pageFormer President, Chief Operating Officer and Secretary$758,139

The full Q32 Bio compensation record

free company brief

This page is one person within Q32 Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Q32 Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Paul Alloway's compensation dossier · One-time report. No refunds.